Journals / Cukurova Medical Journal / 2017 / Cilt: 42 - Sayı: 4

Pulmonary infection caused by Mycobacterium szulgai

Mycobacterium szulgai'nin neden olduğu pulmoner enfeksiyon

Pages
769–771
Publication Date
2017-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When isolated, M. szulgai must be considered as a causative pathogen.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pulmonary infections are the most common manifestations of non-tuberculosis mycobacteria infections.
📊
Key Findings & Data:We report a 54-year-old male patient complaining about cough, hemorrhagic sputum, weakness and weight loss with a history of treated pulmonary tuberculosis.
💡
Conclusion & Impact:When isolated, M. szulgai must be considered as a causative pathogen.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Non-tuberculosis mycobacteria · slowly-growing mycobacteria · pulmonary infection

Abstract

Pulmonary infections are the most common manifestations of non-tuberculosis mycobacteria infections. We report a 54-year-old male patient complaining about cough, hemorrhagic sputum, weakness and weight loss with a history of treated pulmonary tuberculosis. Radiological findings and early-morning gastric fluid mycobacteriological culture indicated fibrocavitary pulmonary infection caused by M. szulgai. The patient was successfully treated with standard 6-month antituberculosis therapy regimen with re-evaluation bimonthly for 12 months. Physicians should consider non-tuberculosis mycobacteria infections for especially individuals with risk factors if it is clinically compatible and supports microbiological findings. When isolated, M. szulgai must be considered as a causative pathogen.

Özet

Pulmoner enfeksiyonlar, tüberküloz dışı mikobakterilerin neden olduğu enfeksiyonların en sık görülen formlarıdır. Öksürük, kanlı balgam, halsizlik ve kilo kaybı şikayetleri olan ve amamnezinde tedavi edilmiş pulmoner tüberküloz hikayesi bulunan 54 yaşında erkek hasta vakasını bildiriyoruz. Radyolojik bulgular ve sabah alınan açlık mide suyunun mikobakteriyolojik kültürü, M.szulgai’nin neden olduğu fibrokaviter akciğer enfeksiyonuna işaret etmiştir. Hasta, 12 ay boyunca her 2 ayda bir yeniden değerlendirilmek üzere standart 6 aylık antitüberküloz tedavi rejimi ile başarıyla tedavi edilmiştir. Klinisyenler, özellikle risk faktörlerini taşıyan bireylerde, klinik uyumluluğun olması ve mikrobiyolojik bulguların da desteklemesi durumunda, tüberküloz dışı mikobakterilerin neden olduğu enfeksiyonları düşünmelidirler. M.szulgai, izole edildiği zaman, enfeksiyon etkeni patojen olarak değerlendirilmelidir.

🔖

Cite This Article

Tekin, K., Ural, F. O., Güney, M., Gümüş, S., SIĞ, A. K., Albay, A. (2017). Pulmonary infection caused by Mycobacterium szulgai. Cukurova Medical Journal, Cilt: 42 - Sayı: 4, 769–771. https://ajindex.com/articles/125413

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Halstrom S, Price P, Thomson R. Review: Environmental mycobacteria as a cause of human infection. Int J Mycobacteriol. 2015;4:81-91
  2. Johnson MM, Odell JA. Nontuberculous mycobacterial pulmonary infections. J Thorac Dis. 2014;6:210-20
  3. Hoefsloot W, Van Ingen J, Andrejak C, Ängeby K, Bauriaud R, Bemer P et al. The geographic diversity of non-tuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42:1604-13
  4. Van Ingen J. Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease. Clin Chest Med. 2015;36:43-54
  5. Bicmen C, Coskun M, Gunduz AT, Senol G, Cirak AK, Tibet G. Nontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not? New Microbiol. 2010;33:399- 403
  6. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367- 416
  7. Philley JV, Griffith DE. Treatment of slowly growing mycobacteria. Clin Chest Med. 2015;36:79-90
  8. Aksamit TR, Philley JV, Griffith DE. Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials. Respir Med. 2014;108:417-25
  9. Babalik A, Kuyucu T, Ordu EN, Ernam D, Partal M, Köksalan K. Non-tuberculous mycobacteria infection: 75 cases. Tuberk Toraks. 2012;60:20-31
  10. Albayrak N, Şimşek H, Sezen F, Arslantürk A, Tarhan G, Ceyhan I. Ulusal tüberküloz referans laboratuvarında 2009-2010 yıllarında tespit edilen tüberküloz dışı mikobakterilerin dağılımlarının irdelenmesi. Mikrobiyol Bul. 2012;46:560-7